Cision PR Newswire

RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias

The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the world's first circular RNA-based in vivo CAR-T therapy achieving FDA IND clearance. RiboX expands its clinical-stage pipeline through its proprietary...

MicroAire appoints Remco Maljers as Head of International Sales

CHARLOTTESVILLE, Va., Jan. 14, 2025 /PRNewswire/ -- MicroAire Surgical Instruments, a Marmon Holdings | Berkshire Hathaway company focused on plastic and upper extremity surgery,...

URSROBOT Celebrates a Successful Showcase of NEXMOW M2 at CES 2025

LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- URSROBOT, a leader in AI-driven robotics, is delighted to announce the resounding success of its presentation of...

Baseus Wins Three Prestigious Awards Following CES 2025 Innovation Honors

LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- Building on the momentum of winning two CES Innovation Awards earlier this year, Baseus has achieved yet another...

ROMOSS Showcases Latest Charging Innovations at CES 2025, Paving the Way for Global Market Expansion

LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- At CES 2025, held from January 7-10 in Las Vegas, ROMOSS captivated global audiences with its latest charging...

BioCina and NovaCina Merger Bolsters Global CDMO Industry

ADELAIDE, South Australia and PERTH, Western Australia, Jan. 14, 2025 /PRNewswire/ -- Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina announced a...

Yaber Shines at CES 2025 with Award-Winning K300s UST Laser Projector

LAS VEGAS, Jan. 14, 2025 /PRNewswire/ -- Yaber, a pioneer in entertainment projectors, has made a significant impact at CES 2025 with the unveiling...